Aadi Biosciences Inc (AADI)

Dec 20, 2024, 8:43 AM EST - 4 weeks ago

Why Is Cancer-Focused Aadi Bioscience Stock Trading Higher On Friday?

Dec 19, 2024, 6:30 PM EST - 4 weeks ago

Aadi Bioscience Transforms with In-Licensing of Novel ADC Portfolio, $100 Million Sale of FYARRO® and $100 Million PIPE Financing

Nov 6, 2024, 8:00 AM EST - 2 months ago

Aadi Bioscience Announces Financial Results for the Third Quarter 2024 and Provides Corporate Update

Oct 30, 2024, 4:05 PM EDT - 2 months ago

Aadi Bioscience to Report Third Quarter 2024 Results and Corporate Update

Aug 20, 2024, 5:00 PM EDT - 5 months ago

Aadi Bioscience Provides PRECISION1 Trial and Corporate Updates

Aug 10, 2024, 10:20 AM EDT - 5 months ago

Aadi Bioscience, Inc. (AADI) Q2 2024 Earnings Call Transcript

Aug 7, 2024, 8:00 AM EDT - 5 months ago

Aadi Bioscience Announces Financial Results for the Second Quarter 2024 and Provides Corporate Update

Jul 31, 2024, 4:05 PM EDT - 6 months ago

Aadi Bioscience to Report Second Quarter 2024 Results and Corporate Update

May 29, 2024, 4:05 PM EDT - 8 months ago

Aadi Bioscience to Participate in the Jefferies Healthcare Conference

May 23, 2024, 5:30 PM EDT - 8 months ago

Aadi Bioscience Presents New Nonclinical Data Demonstrating Preferential Tumor Uptake of nab-Sirolimus at the American Society of Clinical Oncology (ASCO) Annual Meeting

May 8, 2024, 12:58 PM EDT - 9 months ago

Aadi Bioscience, Inc. (AADI) Q1 2024 Earnings Call Transcript

May 8, 2024, 8:00 AM EDT - 9 months ago

Aadi Bioscience Announces Financial Results for the First Quarter 2024 and Provides Corporate Update

May 1, 2024, 8:01 AM EDT - 9 months ago

Aadi Bioscience to Report First Quarter 2024 Results and Corporate Update

Apr 9, 2024, 8:00 AM EDT - 10 months ago

Aadi Bioscience to Present New Non-clinical Data Highlighting Combinability of nab-Sirolimus at the American Association for Cancer Research (AACR) Annual Meeting

Mar 17, 2024, 8:00 AM EDT - 10 months ago

Aadi Bioscience Presents New Subgroup Analysis of Patients with Advanced Malignant PEComa of Gynecologic Origin Treated with nab-Sirolimus at Society of Gynecologic Oncology (SGO)

Mar 13, 2024, 11:43 AM EDT - 11 months ago

Aadi Bioscience, Inc. (AADI) Q4 2023 Earnings Call Transcript

Mar 13, 2024, 8:00 AM EDT - 11 months ago

Aadi Bioscience Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Corporate Update

Mar 6, 2024, 8:00 AM EST - 11 months ago

Aadi Bioscience to Report Fourth Quarter and Full-Year 2023 Results and Corporate Update

Mar 5, 2024, 4:30 PM EST - 11 months ago

Aadi Bioscience to Present Multiple Posters at the American Association for Cancer Research (AACR) Annual Meeting 2024

Mar 1, 2024, 4:08 PM EST - 11 months ago

Aadi Bioscience Announces Publication of Long-Term Efficacy and Safety Data Further Supporting FYARRO® for the Treatment of Malignant PEComa

Feb 26, 2024, 4:05 PM EST - 11 months ago

Aadi Bioscience to Present at the TD Cowen 44th Annual Healthcare Conference

Jan 26, 2024, 4:05 PM EST - 1 year ago

Aadi Bioscience Announces Poster Presentations at the 2024 American Society of Clinical Oncology (ASCO) Genitourinary (GU) Cancers Symposium

Jan 19, 2024, 4:05 PM EST - 1 year ago

Aadi Bioscience Announces Poster Presentations at the 2024 American Society of Clinical Oncology (ASCO) Gastrointestinal (GI) Cancers Symposium

Dec 18, 2023, 7:39 AM EST - 1 year ago

Top 3 Health Care Stocks That Are Preparing To Pump This Month - Durect (NASDAQ:DRRX), Aadi Bioscience (NASDAQ:AADI)

DRRX

Dec 14, 2023, 4:05 PM EST - 1 year ago

Aadi Bioscience Reports Interim Results from PRECISION1 Trial of nab-Sirolimus Demonstrating Anti-Tumor Activity in Solid Tumors with TSC1 or TSC2 Inactivating Alterations

Nov 8, 2023, 12:26 PM EST - 1 year ago

Aadi Bioscience, Inc. (AADI) Q3 2023 Earnings Call Transcript

Nov 8, 2023, 8:00 AM EST - 1 year ago

Aadi Bioscience Reports Financial Results for the Third Quarter 2023 and Provides Corporate Update

Nov 6, 2023, 4:05 PM EST - 1 year ago

Aadi Bioscience to Participate in Jefferies London Healthcare Conference

Nov 1, 2023, 4:05 PM EDT - 1 year ago

Aadi Bioscience to Report Third Quarter 2023 Results and Operational Update

Oct 19, 2023, 4:05 PM EDT - 1 year ago

Aadi Bioscience Announces Poster Presentations on Nab-Sirolimus at the International Gynecologic Cancer Society (IGCS) 2023 Annual Global Meeting

Oct 12, 2023, 4:05 PM EDT - 1 year ago

Aadi Bioscience Announces Poster Presentations at 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

Oct 5, 2023, 4:05 PM EDT - 1 year ago

Aadi Bioscience Announces Poster Presentations at the North American Neuroendocrine Tumor Society (NANETS) 2023 Multidisciplinary NET Medical Symposium

Oct 3, 2023, 4:05 PM EDT - 1 year ago

Aadi Bioscience Grants New CEO Dave Lennon, Ph.D. Inducement Award Under Nasdaq Listing Rule 5635 (c)(4)

Oct 2, 2023, 8:00 AM EDT - 1 year ago

Aadi Bioscience Appoints Dave Lennon, Ph.D. as President and Chief Executive Officer

Sep 5, 2023, 8:00 AM EDT - 1 year ago

Aadi Bioscience to Participate at Upcoming Investor Conferences

Aug 9, 2023, 11:30 AM EDT - 1 year ago

Aadi Bioscience, Inc. (AADI) Q2 2023 Earnings Call Transcript

Aug 9, 2023, 8:00 AM EDT - 1 year ago

Aadi Bioscience Announces Financial Results for the Second Quarter 2023 and Provides Corporate Update

Aug 2, 2023, 8:00 AM EDT - 1 year ago

Aadi Bioscience to Report Second Quarter 2023 Results and Operational Update

Jul 18, 2023, 8:54 AM EDT - 1 year ago

Top 5 Health Care Stocks Which Could Rescue Your Portfolio This MonthSilk Road Me

FGEN INGN SILK THRX

Jun 29, 2023, 6:10 PM EDT - 1 year ago

Aadi Bioscience: High Risk/High Reward

May 25, 2023, 5:30 PM EDT - 1 year ago

Aadi Bioscience Announces Presentations at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

May 23, 2023, 8:00 AM EDT - 1 year ago

Aadi Bioscience to Participate in Upcoming Investor Events

May 10, 2023, 11:33 AM EDT - 1 year ago

Aadi Bioscience, Inc. (AADI) Q1 2023 Earnings Call Transcript

May 10, 2023, 8:00 AM EDT - 1 year ago

Aadi Bioscience Announces Financial Results and Operational Update for the First Quarter 2023 and Provides Update on PRECISION 1 Tumor Agnostic Trial

May 3, 2023, 8:00 AM EDT - 1 year ago

Aadi Bioscience to Report First Quarter 2023 Results and Operational Update

Apr 26, 2023, 4:05 PM EDT - 1 year ago

Aadi Bioscience Announces Multiple Presentations on nab-Sirolimus at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

Apr 14, 2023, 1:09 PM EDT - 1 year ago

Aadi Bioscience to Present Multiple Posters on nab-Sirolimus at the 2023 American Association for Cancer Research (AACR) Annual Meeting

Apr 6, 2023, 4:35 PM EDT - 1 year ago

Aadi Bioscience to Present Multiple Posters at the American Association for Cancer Research (AACR) Annual Meeting 2023

Mar 28, 2023, 11:36 AM EDT - 1 year ago

Aadi Bioscience, Inc. (AADI) Q4 2022 Earnings Call Transcript

Mar 28, 2023, 8:00 AM EDT - 1 year ago

Aadi Bioscience Announces Financial Results for the Fourth Quarter and Full-Year 2022 and Provides Corporate Update